On Friday the S&P/ASX 200 Index (ASX: XJO) finished a positive week on a disappointing note. The benchmark index fell 0.6% to 6,642.6 points.
Will the market be able to bounce back from this on Monday? Here are five things to watch:
ASX futures pointing slightly lower.
It looks set to be a subdued start to the week for the Australian share market. According to the latest SPI futures, the ASX 200 is poised to open the week a single point lower this morning. This follows a mixed end to the week on Wall Street. On Friday night the Dow Jones rose 0.15%, the S&P 500 fell 0.15%, and the Nasdaq dropped 0.2%.
ASX 200 new additions.
S&P Dow Jones Indices has announced its quarterly rebalance of the S&P/ASX Indices. The ASX 200 will be welcoming online retailer Kogan.com Ltd (ASX: KGN) and plumbing parts company Reece Ltd (ASX: REH) at the open of trading on December 21. Heading out of the index are three shares, due to the index currently having 201 shares following a demerger. These are Avita Therapeutics Inc (ASX: AVH), Cooper Energy Ltd (ASX: COE), and Western Areas Ltd (ASX: WSA).
Oil prices soften.
Energy producers including Santos Ltd (ASX: STO) and Woodside Petroleum Limited (ASX: WPL) could come under pressure today after oil prices finished the week in the red. According to Bloomberg, the WTI crude oil price fell 0.45% to US$46.57 a barrel and the Brent crude oil price dropped 0.55% to US$49.97 a barrel. Despite this, oil prices were able to record their sixth successive weekly gain.
Gold price rises.
Gold miners such as Newcrest Mining Limited (ASX: NCM) and Northern Star Resources Ltd (ASX: NST) will be on watch today after the spot gold price pushed higher on Friday. According to CNBC, the spot gold price rose 0.35% lower to US$1,843.60 an ounce. COVID-19 stimulus optimism in the US lifted the precious metal.
US approves Pfizer COVID-19 vaccine.
On Friday night the US FDA gave its authorisation for the emergency use of Pfizer’s COVID-19 vaccine. According to CNBC, the FDA’s emergency use authorisation will allow the federal government’s distribution of the potentially lifesaving vaccine across the country immediately. The government has already distributed 2.9 million doses of the vaccine, with the first jabs expected later today.
Where to invest $1,000 right now
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.
*Returns as of June 30th
More reading
- 10 highly rated ASX shares to buy in 2021
- Top brokers name 3 ASX shares to sell next week
- 5 things to watch on the ASX 200 next week
- These were the best performing ASX 200 shares last week
- These were the worst performing ASX 200 shares last week
James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Avita Medical Limited and Kogan.com ltd. The Motley Fool Australia has recommended Avita Medical Limited and Kogan.com ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.
The post 5 things to watch on the ASX 200 on Monday appeared first on The Motley Fool Australia.
from The Motley Fool Australia https://ift.tt/3oP0zfT
Leave a Reply